These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8393742)

  • 1. Studies on human serum paraoxonase/arylesterase.
    La Du BN; Adkins S; Kuo CL; Lipsig D
    Chem Biol Interact; 1993 Jun; 87(1-3):25-34. PubMed ID: 8393742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The polymorphic paraoxonase/arylesterase isozymes of human serum.
    La Du BN; Eckerson HW
    Fed Proc; 1984 May; 43(8):2338-41. PubMed ID: 6325253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes.
    Adkins S; Gan KN; Mody M; La Du BN
    Am J Hum Genet; 1993 Mar; 52(3):598-608. PubMed ID: 7916578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human serum paraoxonase/arylesterase polymorphism.
    Eckerson HW; Wyte CM; La Du BN
    Am J Hum Genet; 1983 Nov; 35(6):1126-38. PubMed ID: 6316781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R.
    Aviram M; Billecke S; Sorenson R; Bisgaier C; Newton R; Rosenblat M; Erogul J; Hsu C; Dunlop C; La Du B
    Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1617-24. PubMed ID: 9763535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities.
    Gan KN; Smolen A; Eckerson HW; La Du BN
    Drug Metab Dispos; 1991; 19(1):100-6. PubMed ID: 1673382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase.
    Smolen A; Eckerson HW; Gan KN; Hailat N; La Du BN
    Drug Metab Dispos; 1991; 19(1):107-12. PubMed ID: 1673383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An improved method for phenotyping individuals for the human serum paraoxonase arylesterase polymorphism.
    La Du BN; Piko JI; Eckerson HW; Vincent-Viry M; Siest G
    Ann Biol Clin (Paris); 1986; 44(4):369-72. PubMed ID: 3024532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraoxonase polymorphism in rabbits.
    Zech R; Severin RM; Chemnitius JM; Nebendahl K
    Chem Biol Interact; 1999 May; 119-120():283-8. PubMed ID: 10421463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the serum paraoxonase/arylesterase polymorphism in a Turkish population.
    Karakaya A; Suzen S; Sardas S; Karakaya AE; Vural N
    Pharmacogenetics; 1991 Oct; 1(1):58-61. PubMed ID: 1668963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat inactivation of paraoxonase and arylesterase activities in human and rabbit serum.
    Simeon V; Pavković E
    Chem Biol Interact; 1993 Jun; 87(1-3):103-7. PubMed ID: 8393733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoproteins and hydrolysis of organophosphorus compounds.
    Zech R; Röckseisen M; Kluge K; Dewald K; Armstrong VW; Chemnitius JM
    Chem Biol Interact; 1993 Jun; 87(1-3):85-94. PubMed ID: 8393751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxon hydrolysis in human serum mediated by a genetically variable arylesterase and albumin.
    Ortigoza-Ferado J; Richter RJ; Hornung SK; Motulsky AG; Furlong CE
    Am J Hum Genet; 1984 Mar; 36(2):295-305. PubMed ID: 6324579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of two rat liver proteins with paraoxonase activity: biochemical evidence for the identity of paraoxonase and arylesterase.
    Rodrigo L; Gil F; Hernández AF; Pla A
    Chem Biol Interact; 1999 May; 119-120():263-75. PubMed ID: 10421461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum paraoxonase and arylesterase activities in hemodialysis patients.
    Itahara T; Suehiro T; Ikeda Y; Inoue M; Nakamura T; Kumon Y; Kawada M; Hashimoto K
    J Atheroscler Thromb; 2000; 7(3):152-8. PubMed ID: 11480456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular basis of the human serum paraoxonase activity polymorphism.
    Humbert R; Adler DA; Disteche CM; Hassett C; Omiecinski CJ; Furlong CE
    Nat Genet; 1993 Jan; 3(1):73-6. PubMed ID: 8098250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinction between 'A'-esterases and arylesterases. Implications for esterase classification.
    Mackness MI; Thompson HM; Hardy AR; Walker CH
    Biochem J; 1987 Jul; 245(1):293-6. PubMed ID: 2822017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of esterases in plasma from Ghanaian and British subjects.
    Williams FM; Nicholson EN; Woolhouse NW; Adjepon-Yamoah KK; Rawlins MD
    Eur J Clin Pharmacol; 1986; 31(4):485-9. PubMed ID: 3028817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ratio of serum paraoxonase/arylesterase activity using an improved assay for arylesterase activity to discriminate PON1(R192) from PON1(Q192).
    Nakanishi M; Takanami Y; Maruyama T; Murata M; Motohashi Y; Nakano S; Uchida K; Maruyama C; Kyotani S; Tsushima M
    J Atheroscler Thromb; 2003; 10(6):337-42. PubMed ID: 15037822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interindividual variations in enzymes controlling organophosphate toxicity in man.
    Mutch E; Blain PG; Williams FM
    Hum Exp Toxicol; 1992 Mar; 11(2):109-16. PubMed ID: 1349216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.